Janus Henderson Group PLC Neogenomics Inc Transaction History
Janus Henderson Group PLC
- $188 Billion
- Q4 2024
A detailed history of Janus Henderson Group PLC transactions in Neogenomics Inc stock. As of the latest transaction made, Janus Henderson Group PLC holds 6,165,063 shares of NEO stock, worth $88.9 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
6,165,063
Previous 6,603,180
6.63%
Holding current value
$88.9 Million
Previous $97.4 Million
4.32%
% of portfolio
0.05%
Previous 0.05%
Shares
31 transactions
Others Institutions Holding NEO
# of Institutions
283Shares Held
123MCall Options Held
622KPut Options Held
72.2K-
Black Rock Inc. New York, NY19.7MShares$284 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.2MShares$205 Million0.0% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.53MShares$94.1 Million0.07% of portfolio
-
Brown Advisory Inc6.16MShares$88.8 Million0.13% of portfolio
-
State Street Corp Boston, MA5.2MShares$75 Million0.0% of portfolio
About NEOGENOMICS INC
- Ticker NEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 125,796,000
- Market Cap $1.81B
- Description
- NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...